Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III study finds Xywav improves excessive daytime sleepiness

April 23, 2021

Studies reveal activity, mechanism of TAM kinase inhibitor PF-5807

April 23, 2021

CVL-231 safe in healthy volunteers; evaluation in schizophrenia patients ongoing

April 23, 2021

PCSK9 affects antitumor immunity

April 22, 2021

Bharat reports second interim analysis of phase III study of Covaxin COVID-19 vaccine candidate

April 22, 2021

Treatment begins in clinical trial of GNT-0004 gene therapy for Duchenne muscular dystrophy

April 22, 2021

Valneva begins pivotal trial of COVID-19 vaccine candidate VLA-2001

April 22, 2021

AN-3025: an anti-TNFR2 antibody for cancer immunotherapy

April 22, 2021

SAB-185 studied as part of ACTIV-2 trial for treatment of COVID-19

April 22, 2021

Targeting the adenosine pathway for cancer immunotherapy

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...